Angela L. Tyner

8.2k total citations · 2 hit papers
91 papers, 6.8k citations indexed

About

Angela L. Tyner is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Angela L. Tyner has authored 91 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 49 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Angela L. Tyner's work include Cancer-related Molecular Pathways (27 papers), Melanoma and MAPK Pathways (19 papers) and Cytokine Signaling Pathways and Interactions (14 papers). Angela L. Tyner is often cited by papers focused on Cancer-related Molecular Pathways (27 papers), Melanoma and MAPK Pathways (19 papers) and Cytokine Signaling Pathways and Interactions (14 papers). Angela L. Tyner collaborates with scholars based in United States, Canada and South Korea. Angela L. Tyner's co-authors include Andrei L. Gartel, Michael S. Serfas, Pradip Raychaudhuri, Eugene Goufman, Robert H. Costa, Elaine Fuchs, E. Fuchs, Lester F. Lau, Feridoon Najmabadi and Marjorie Rosenberg and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Angela L. Tyner

90 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

2002 809 citations Andrei L. Gartel, Angela L. Tyner profile →
Transcriptional Regulation of the p21(WAF1/CIP1)Gene

1999 569 citations Andrei L. Gartel, Angela L. Tyner profile →

Peers

Countries citing papers authored by Angela L. Tyner

Since Specialization

Citations

This map shows the geographic impact of Angela L. Tyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela L. Tyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela L. Tyner more than expected).

Fields of papers citing papers by Angela L. Tyner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela L. Tyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela L. Tyner. The network helps show where Angela L. Tyner may publish in the future.

Co-authorship network of co-authors of Angela L. Tyner

This figure shows the co-authorship network connecting the top 25 collaborators of Angela L. Tyner. A scholar is included among the top collaborators of Angela L. Tyner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela L. Tyner. Angela L. Tyner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Appearance of tuft cells during prostate cancer progression 2023 ·Oncogene ·(unknown), (unknown), Wenjun Bie, Bradley J. Merrill, Larisa Nonn, Andre Kajdacsy‐Balla, Angela L. Tyner	2
2	Targeting protein tyrosine kinase 6 in cancer 2020 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·(unknown), Angela L. Tyner	17
3	PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer 2017 ·Nature Communications ·(unknown), Andre Kajdacsy‐Balla, Virgilia Macias, (unknown), (unknown), Wenjun Bie, Angela L. Tyner	61
4	Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer 2016 ·Molecular Cancer Research ·Priya Mathur, Jessica J. Gierut, Grace Guzman, Hui Xie, Rosa M. Xicola, Xavier Llor, (unknown), Ansu O. Perekatt, Angela L. Tyner	22
5	Brk/Protein Tyrosine Kinase 6 Phosphorylates p27 ^KIP1 , Regulating the Activity of Cyclin D–Cyclin-Dependent Kinase 4 2015 ·Molecular and Cellular Biology ·(unknown), Benedikt Asbach, (unknown), (unknown), Alexander Coltoff, (unknown), Angela L. Tyner, Ralf Wagner, Stacy W. Blain	35
6	Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma 2013 ·Molecular Cancer Therapeutics ·Zebin Wang, Yu Zheng, Hyun-Jung Park, Jing Li, Janai R. Carr, Yi–Ju Chen, (unknown), Dragana Kopanja, Srilata Bagchi, Angela L. Tyner, Pradip Raychaudhuri	18
7	FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors 2011 ·Cancer Research ·Zebin Wang, Hyun Jung Park, Janai R. Carr, Yi–Ju Chen, Yu Zheng, Jing Li, Angela L. Tyner, Robert H. Costa, Srilata Bagchi, Pradip Raychaudhuri	80
8	Cytoplasmic retention of protein tyrosine kinase 6 promotes growth of prostate tumor cells 2010 ·Cell Cycle ·Patrick M. Brauer, Yu Zheng, Lin Wang, Angela L. Tyner	27
9	Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats 2009 ·Growth Hormone & IGF Research ·Robert E. Carroll, Robert A. Goodlad, Aleksandra J. Poole, Angela L. Tyner, R. Brooks Robey, Steven M. Swanson, Terry G. Unterman	12
10	RAKing in AKT: A tumor suppressor function for the intracellular tyrosine kinase FRK 2009 ·Cell Cycle ·Patrick M. Brauer, Angela L. Tyner	31
11	A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1 2009 ·Journal of Biological Chemistry ·Yi–Ju Chen, Carmen Dominguez‐Brauer, Zebin Wang, John M. Asara, Robert H. Costa, Angela L. Tyner, Lester F. Lau, Pradip Raychaudhuri	83
12	FoxM1, a critical regulator of oxidative stress during oncogenesis 2009 ·The EMBO Journal ·Hyun Jung Park, Janai R. Carr, Zebin Wang, Véronique Nogueira, Nissim Hay, Angela L. Tyner, Lester F. Lau, Robert H. Costa, Pradip Raychaudhuri	193
13	Anaphase-Promoting Complex/Cyclosome-Cdh1-Mediated Proteolysis of the Forkhead Box M1 Transcription Factor Is Critical for Regulated Entry into S Phase 2008 ·Molecular and Cellular Biology ·Hyun Jung Park, Robert H. Costa, Lester F. Lau, Angela L. Tyner, Pradip Raychaudhuri	98
14	Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells 2003 ·Oncogene ·(unknown), Gail S. Prins, Vera Ray, Angela L. Tyner	110
15	Sik (BRK) Phosphorylates Sam68 in the Nucleus and Negatively Regulates Its RNA Binding Ability 2000 ·Molecular and Cellular Biology ·(unknown), Stéphane Richard, (unknown), Xin Ye, Valeri Vasioukhin, Alan Cochrane, Taiping Chen, Angela L. Tyner	130
16	A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription 2000 ·Oncogene ·Andrei L. Gartel, Feridoon Najmabadi, Eugene Goufman, Angela L. Tyner	48
17	Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line 2000 ·Oncogene ·Andrei L. Gartel, Eugene Goufman, Feridoon Najmabadi, Angela L. Tyner	68
18	Developmental Regulation of α-Fetoprotein Expression in Intestinal Epithelial Cells of Transgenic Mice 1995 ·Developmental Biology ·Lisa Ann Cirillo, (unknown), Jean Vacher, Angela L. Tyner	6
19	Laminin receptor expression in rat intestine and liver during development and differentiation 1994 ·Gastroenterology ·(unknown), (unknown), Yogesh Maheshwari, Donald E. Sykes, (unknown), Angela L. Tyner, Milton M. Weiser	21
20	The zonal expression of α‐fetoprotein transgenes in the livers of adult mice 1992 ·Developmental Dynamics ·(unknown), Jean Vacher, Lisa Ann Cirillo, S M Tilghman, Angela L. Tyner	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact